Can hypothyroidism cause apraxia of speech?

Last updated 2026-07-10

There's a real connection here, but it's not a clean one-to-one cause. Thyroid hormone runs normal brain development and keeps the neural pathways for voluntary movement working, including the fast, sequenced movements the mouth and tongue need for speech. When thyroid hormone runs low, those pathways can develop atypically or degrade over time, and the result can look a lot like apraxia of speech.

Apraxia of speech is a motor planning problem, not muscle weakness and not a language comprehension problem. The brain knows what it wants to say; it just can't reliably tell the lips and tongue how to get there ^[1]. When hypothyroidism damages the neural infrastructure behind that planning, you get exactly those errors: articulation that shifts from try to try, groping mouth movements, longer words that collapse while short ones hold together.

Hypothyroidism is not the usual reason a child has apraxia. Most cases have no identified cause at all, and genetic factors, prematurity, and other neurological conditions show up far more often in the research. But hypothyroidism sits in the small group of treatable underlying conditions that every clinician should rule out early, because fixing the cause can change the whole trajectory.

How thyroid hormone shapes brain development and speech

Thyroid hormone (mainly T3 and T4) is one of the strongest regulators of fetal and infant brain development. It drives neuronal migration, myelination, and synapse formation during windows that mostly don't reopen. The stretch from the second trimester through roughly the first two years of life is when deficiency does the most damage ^[2].

Myelination matters most here. Myelin is the insulating sheath around nerve fibers that lets signals travel fast and clean. The corticobulbar tract carries motor commands from the cortex down to the muscles of the face, lips, tongue, and larynx, and it needs intact myelin to work. Poor myelination in that tract produces delayed, inconsistent, degraded motor signals, which is close to the mechanism behind apraxia of speech ^[3].

In adults, acquired hypothyroidism can cause cerebellar dysfunction, because thyroid hormone keeps Purkinje cells healthy. That shows up as ataxic dysarthria and, in some documented cases, acquired apraxia-like speech. A 2019 review in the journal Thyroid noted that central nervous system effects of hypothyroidism include cerebellar ataxia, cognitive slowing, and motor coordination deficits, all of which can hit speech ^[4].

So the chain runs like this: thyroid deficiency disrupts neural development or degrades neural function, that interferes with the circuitry for motor planning and sequencing, and the output is speech that looks and sounds like apraxia.

Congenital hypothyroidism and speech delay

This is where the evidence is strongest. Congenital hypothyroidism (CH) is one of the most common preventable causes of intellectual and developmental disability worldwide, and newborn screening exists specifically because early treatment changes outcomes so much ^[5].

Congenital hypothyroidism affects roughly 1 in 2,000 to 1 in 4,000 newborns in the United States, making it one of the most common congenital endocrine disorders ^[5]. Babies caught through newborn screening and treated fast (usually within the first two weeks of life) still show measurable differences in language development compared to controls. A 2012 study in the Journal of Pediatrics found that children with congenital hypothyroidism, despite early levothyroxine treatment, scored significantly lower on expressive language and phonological processing tests than healthy peers ^[6].

Speech-specific findings from that and related research include higher rates of phonological disorders and motor speech errors, slower speech development in the first three years, more inconsistent articulation errors (a hallmark of apraxia), and more trouble with longer, multisyllabic words than with short ones.

Not every child with CH develops clinical apraxia. But the speech motor profile is consistent enough that childhood apraxia of speech belongs on the differential whenever a child with CH has speech difficulties, and it's worth pushing for an evaluation by a speech-language pathologist who knows motor speech. Early intervention matters enormously here too: the same neurological windows that make early hypothyroidism so damaging are the windows during which intensive speech therapy produces the best results.

What it looks like when thyroid disease is involved

The speech itself doesn't change based on the cause. Genetic variant, stroke, or thyroid deficiency, the visible features stay the same: articulation errors that shift from attempt to attempt, more errors on longer words, groping or effortful mouth movements, flat or choppy prosody, and a pattern where a child can nail a sound once and then miss it the very next try ^[1].

What differs is the wider clinical picture. A child with CH and apraxia often also has delayed motor milestones like sitting or walking (since thyroid deficiency hits the whole motor system), cognitive or learning differences especially with memory and processing speed, feeding difficulties in infancy as an early sign of oral-motor dyscoordination, and sometimes a history of low birth weight or neonatal jaundice.

In adults with acquired hypothyroidism, the picture can also include a rough, low-pitched voice from laryngeal edema, slow speech, and word-finding pauses. Those come more from dysarthria or general language slowing than from apraxia proper, so the presentation is usually mixed. Sorting apraxia from dysarthria matters, because they need different therapy, and a speech therapy evaluation should work out which one dominates. One red flag stands out: if a child's speech was developing normally and then regressed, test thyroid function early. Regression isn't typical for idiopathic developmental apraxia, but it does fit a systemic medical cause.

Getting a diagnosis

Diagnosis runs on two tracks at once, and the common family mistake is finishing one before starting the other.

The first track is the endocrine workup. For children it usually starts with TSH (thyroid-stimulating hormone) and free T4. Elevated TSH with low free T4 confirms primary hypothyroidism. In the U.S., newborn screening catches most congenital cases at birth through the mandatory heel-stick, but acquired hypothyroidism can show up later and needs its own evaluation. The American Academy of Pediatrics recommends repeat thyroid screening at set intervals for children with Down syndrome, Turner syndrome, or a family history of thyroid disease ^[7].

The second track is the speech-language evaluation. The Diagnostic Evaluation of Articulation and Phonology (DEAP), the Dynamic Evaluation of Motor Speech Skill (DEMSS), and the Goldman-Fristoe Test of Articulation come up often. The SLP should look specifically for the inconsistency and motor sequencing breakdown that mark apraxia, rather than just tallying articulation errors.

A normal thyroid result doesn't rule out apraxia; it just means the cause is somewhere else. If thyroid function is abnormal, levothyroxine should start promptly under a pediatrician or pediatric endocrinologist, and speech therapy should start at the same time, not after. Blood work alone will never tell you whether the problem is apraxia, dysarthria, a phonological disorder, or some blend, that's the SLP's job. Skipping the speech evaluation while you wait to see if thyroid medication fixes the speech is a real and costly mistake.

Will treating the thyroid fix the speech on its own?

Sometimes partially, rarely completely, and never reliably without speech therapy running alongside it.

In children with congenital hypothyroidism, early levothyroxine prevents the worst neurological outcomes and greatly improves general cognitive and motor development. But the 2012 Journal of Pediatrics study noted above found that even optimally treated CH children still showed speech and language deficits versus controls, which suggests some differences in speech circuitry hold on despite normal thyroid levels ^[6].

In adults with acquired hypothyroidism, getting back to euthyroid status (normal thyroid hormone levels) can reverse some neurological symptoms, including cerebellar ataxia and slowed motor processing. Case reports in the endocrinology literature describe patients whose speech improved a lot after starting levothyroxine. But those tend to be dysarthria or general motor slowing rather than true apraxia, and neurological recovery is slow, often taking months.

For children with diagnosed childhood apraxia of speech (CAS) plus hypothyroidism, both the current evidence and ASHA's practice guidance point the same way: treat the medical cause and run intensive motor speech therapy at the same time ^[1]. Waiting to see if the medication works before starting therapy burns developmental time you can't get back.

The practical version: treat the thyroid, yes, but also get the child into speech therapy right away. These aren't competing choices, they're both part of the same plan.

What actually helps with apraxia, no matter the cause

The cause of a child's apraxia doesn't change much about which therapy works. The motor planning system responds to intensive, repetitive, carefully sequenced practice no matter why it broke down in the first place.

The two approaches with the strongest evidence for childhood apraxia of speech are the Nuffield Dyspraxia Programme (NDP3) and Dynamic Temporal and Tactile Cueing (DTTC), both built specifically for motor speech ^[8]. DTTC has the child produce sounds simultaneously with the therapist, then fades that support as accuracy improves, working the brain's motor learning system directly. For older children and adults, Rapid Syllable Transition Treatment (ReST) targets the transitions between syllables rather than single sounds, which is usually where apraxia falls apart.

Frequency matters more here than for almost any other speech disorder. Research generally supports at least three to five sessions a week during intensive blocks, each with a high number of practice trials, often 100 or more. Once-weekly therapy probably isn't enough for moderate to severe CAS. Parent-delivered practice between sessions has strong support too: the SLP sets the targets, and the family runs them daily. That's one reason apps and structured home programs can genuinely add to clinic care. Little Words, for instance, is built for neurodivergent kids who need frequent, structured speech practice between sessions, and if you're unsure whether your child's profile fits, the start quiz can point you in a direction.

For children with hypothyroidism who also have broader developmental delays, the speech work usually needs to sit inside a wider therapy plan addressing motor coordination overall, not just articulation.

Other thyroid conditions that touch speech

The thyroid-speech link runs past congenital hypothyroidism. Hashimoto's thyroiditis is the most common cause of hypothyroidism in children in the U.S., and it can drive subclinical hypothyroidism that goes missed for months or years. There's growing clinical interest in whether even mildly elevated TSH in school-age children slows cognitive processing and language, though the research here is thinner than for overt CH.

Maternal hypothyroidism during pregnancy is a separate and underrated risk. The mother's thyroid hormone crosses the placenta and is the fetal brain's only source during the first trimester, before the fetal thyroid switches on. A 2019 study in the New England Journal of Medicine found that children born to mothers with untreated subclinical hypothyroidism did not have significantly lower IQ scores at age 5, which complicated an earlier assumption ^[9]. Smaller studies have tied it to language delay specifically, so this remains an open question. The honest read is that the data are mixed, which is a good reason to talk to your OB about thyroid screening during pregnancy.

Hyperthyroidism, an overactive thyroid, has a much weaker and less documented link to speech problems. It can cause tremor and rapid, pressured speech in adults, but it doesn't produce the motor planning deficits seen in apraxia. Iodine deficiency causing hypothyroidism is rare in the U.S. thanks to iodized salt, but it's still a major cause of developmental language and speech delay globally, worth naming for families in regions where iodine deficiency persists.

When to ask for a thyroid test

You don't need to hit some threshold of suspicion first. Thyroid testing is a simple blood draw, and it belongs in any workup for a child with unexplained speech or language delay, especially motor speech delay.

The American Academy of Pediatrics' Bright Futures guidelines call for developmental surveillance at every well-child visit and formal screening at 9, 18, and 30 months ^[10]. They don't name thyroid testing as a universal part of a speech delay workup, but most pediatric developmental specialists add it when motor speech difficulties go beyond simple articulation errors, when the child shows signs of possible metabolic or endocrine involvement (growth concerns, fatigue, constipation, dry skin, delayed reflexes), when there's a family history of thyroid disease, when the child has Down syndrome, Turner syndrome, or another chromosomal condition with elevated thyroid risk, or when developmental regression has occurred.

For adults with new speech difficulties that include motor coordination problems, thyroid function is part of the standard neurological workup and should be checked as a matter of course.

If you're the parent pushing for the test, keep it simple. Ask the pediatrician: "Can we check TSH and free T4 as part of the workup for his speech motor delays?" A reasonable pediatrician will say yes, and you don't need a referral just to ask.

How outcomes compare across causes

Here the data get thin, so here's what's honest to say. Children with congenital hypothyroidism who are diagnosed early and treated fast have meaningfully better speech and language outcomes than those diagnosed late. Newborn screening in the U.S. has sharply cut the rate of severe speech and cognitive impairment from CH, which is a genuine public health win.

Compared to idiopathic CAS (apraxia with no identified cause), children with CH and apraxia may carry a broader set of developmental needs, since the thyroid deficiency often affects more than speech. That's not a reason for pessimism, just a reason to build a bigger team: speech-language pathology, developmental pediatrics, occupational therapy for wider motor coordination, and educational support as needed.

Compared to CAS from genetic variants like FOXP2, or CAS following a brain injury, the outlook for hypothyroidism-related apraxia after proper treatment is generally seen as favorable, because the medical cause itself is correctable. A brain that develops after thyroid levels normalize has a better setting for motor learning to begin with.

Response to speech therapy for motor speech disorders isn't strongly predicted by cause. It's predicted far better by therapy intensity, home practice consistency, age at start, and severity at baseline. A child with CH and apraxia who starts intensive early intervention before age three can make substantial progress.

What to do if you suspect this connection

Don't wait for one provider to connect all the dots. The medical system tends to silo endocrinology and speech-language pathology, so you may end up being the one who brings the two conversations together.

Start by calling the pediatrician and asking specifically for a TSH and free T4 blood test. If your child already sees a pediatric endocrinologist, say the speech concerns out loud and ask whether the degree of thyroid involvement fits the speech profile. Next, schedule a full speech-language evaluation with an SLP who has real experience in motor speech disorders, and ask directly whether the evaluation will check for childhood apraxia of speech rather than just articulation or phonological skills. Not every SLP has deep CAS expertise, and it's fine to ask about theirs.

If early intervention services (for children under 3) or school-based services (ages 3 and up) aren't in place, start that process now. In the U.S., Part C of the Individuals with Disabilities Education Act (IDEA) entitles children under 3 with developmental delays to free evaluation and services, and Part B covers ages 3 through 21 ^[11].

Finally, set up supplemental practice at home. Clinic therapy once a week is often not enough for apraxia; daily practice, guided by the SLP's targets, is what moves the needle. Tools like Little Words can structure that daily practice for families working through neurodivergent speech development.

Nobody has a clear picture of how often hypothyroidism is the undiagnosed driver behind an apraxia presentation. But thyroid testing is cheap, fast, and treatable if it comes back positive, so there's no good reason to skip it.

Frequently asked questions

Can hypothyroidism cause apraxia of speech in toddlers?

Yes, particularly with congenital hypothyroidism or hypothyroidism acquired during early childhood. Thyroid hormone is essential for the myelination and synapse development behind motor speech planning. Children with congenital hypothyroidism show higher rates of motor speech errors, including patterns consistent with apraxia, even when treated early. Any toddler with unexplained motor speech difficulties should have thyroid function checked as part of the diagnostic workup.

What are the speech symptoms of hypothyroidism in adults?

In adults, hypothyroidism can cause slow, effortful speech, a low or rough voice (from laryngeal edema), reduced speech rate, and sometimes cerebellar ataxia that affects speech coordination. These features overlap more with dysarthria than with classic apraxia, though the two can coexist. Word-finding slowness from the cognitive effects of hypothyroidism is common too. Symptoms often improve a lot after levothyroxine, though full neurological recovery can take months.

Is childhood apraxia of speech a symptom of thyroid disease?

It can be, but it is not the most common cause. Most childhood apraxia of speech has no clearly identified cause. Thyroid disease is one of several treatable medical conditions that can produce or add to apraxia-like speech patterns, and it should be ruled out. Other medical causes to consider include chromosomal conditions, genetic variants like FOXP2, metabolic disorders, and brain injury. A thorough evaluation covers all of these.

Does Hashimoto's thyroiditis cause speech problems in children?

Hashimoto's can cause speech and language effects if it produces clinically significant hypothyroidism. Subclinical hypothyroidism from Hashimoto's sometimes gets dismissed as not severe enough to treat, but there is ongoing clinical debate about whether even mild thyroid underfunction affects cognitive and language processing in growing children. If a child with Hashimoto's has speech or language concerns, ask for a speech-language evaluation alongside ongoing endocrine monitoring.

Can maternal hypothyroidism during pregnancy cause apraxia in the baby?

Maternal thyroid hormone is the fetal brain's only source during the first trimester, so significant maternal hypothyroidism in pregnancy poses a real neurological risk to the developing fetus. Research is mixed, particularly for subclinical maternal hypothyroidism. For overt maternal hypothyroidism, levothyroxine treatment during pregnancy is standard and clearly benefits fetal neurodevelopment. Speech and language delays in children born to mothers with untreated pregnancy hypothyroidism have shown up in smaller studies.

How quickly does speech improve after starting thyroid medication?

It varies a lot by age, severity, and how long the deficiency went untreated. In adults, some neurological symptoms start improving within weeks of starting levothyroxine, but full recovery can take six to twelve months or longer. In children, the trajectory depends on when treatment started relative to critical neurodevelopmental windows. Early treatment produces better outcomes, but most children with hypothyroidism and apraxia still benefit from structured speech therapy alongside medication.

What blood tests detect hypothyroidism in a child with speech delays?

The standard first-line tests are TSH (thyroid-stimulating hormone) and free T4. Elevated TSH with low free T4 confirms primary hypothyroidism. Some clinicians also test free T3 and thyroid antibodies (anti-TPO, anti-thyroglobulin) if Hashimoto's is suspected. These are standard blood draws done at any pediatric lab. Newborn screening already tests TSH in most U.S. states, but acquired hypothyroidism needs a separate test ordered by the child's doctor.

Is there a genetic link between thyroid disease and apraxia of speech?

There is no direct shared genetic cause established between thyroid disease and apraxia of speech. The connection is physiological: thyroid hormone deficiency disrupts neurological development, which can produce apraxia. Separately, some genetic syndromes that include thyroid abnormalities (Down syndrome, for example) also carry higher rates of speech and motor delays. The FOXP2 gene is associated with childhood apraxia of speech but is not linked to thyroid function.

Should a child with apraxia be tested for thyroid problems?

Yes, especially with any other signs of metabolic or endocrine involvement, developmental regression, broader motor delays, or a family history of thyroid disease. Thyroid testing is cheap and non-invasive against the payoff of catching a treatable cause. ASHA's practice guidance on childhood apraxia of speech recommends a full medical evaluation to rule out underlying causes, and thyroid function fits naturally in that workup.

What speech therapy is used for apraxia caused by hypothyroidism?

The same approaches used for any motor speech disorder: Dynamic Temporal and Tactile Cueing (DTTC), Nuffield Dyspraxia Programme (NDP3), and Rapid Syllable Transition Treatment (ReST) carry the strongest evidence for childhood apraxia of speech. Frequency matters more than technique: three to five sessions per week with high practice-trial counts is the target. Parent-delivered daily home practice between clinic sessions speeds progress a lot.

Can subclinical hypothyroidism cause speech delay?

The evidence is less clear-cut here than for overt hypothyroidism, but subclinical hypothyroidism (elevated TSH with normal free T4) in infants and young children has been tied to language and developmental delays in some studies. Clinicians disagree on whether to treat subclinical hypothyroidism in children. If a child with subclinical hypothyroidism also has speech delays, that is worth a specific conversation with a pediatric endocrinologist about treatment thresholds.

How common is congenital hypothyroidism in the United States?

Congenital hypothyroidism affects roughly 1 in 2,000 to 1 in 4,000 newborns in the United States, making it one of the most common congenital endocrine disorders. All 50 states include TSH or T4 testing in the mandatory newborn screening panel. Early detection through screening and prompt levothyroxine treatment have sharply reduced rates of severe intellectual disability and developmental delay from this condition.

Can hypothyroidism cause echolalia or autism-like speech in children?

Severe or prolonged hypothyroidism in early childhood can cause broad neurodevelopmental effects that may include repetitive or delayed speech patterns. Echolalia specifically is more often tied to autism spectrum disorder, but any condition that disrupts early language development can produce similar-looking behaviors. If a child shows both thyroid abnormalities and autism-like communication, a full developmental evaluation is needed. Learn more in our guide to echolalia meaning.

What other conditions should be ruled out alongside hypothyroidism in a child with motor speech delays?

A thorough workup for childhood apraxia of speech usually considers genetic factors (microarray, specific gene panels if indicated), metabolic disorders, structural brain differences (MRI if clinically indicated), hearing loss, and broader neurological conditions. Thyroid function sits alongside these as part of a standard medical evaluation. An SLP evaluation should run in parallel, not wait for all medical results to come back.

Sources

1. ASHA (American Speech-Language-Hearing Association), Childhood Apraxia of Speech Practice Portal: Apraxia of speech is a motor speech disorder involving impaired planning and sequencing of movements for speech, not muscle weakness or language comprehension deficits
2. NIH National Institute of Diabetes and Digestive and Kidney Diseases, Hypothyroidism: Thyroid hormone is critical to fetal and infant brain development, with deficiency during early life causing irreversible neurological damage
3. Developmental Medicine and Child Neurology, research on myelination and thyroid hormone in the developing brain (via PubMed): Thyroid hormone deficiency disrupts myelination of corticobulbar and other motor tracts, impairing the speed and reliability of motor command transmission
4. Thyroid (Mary Ann Liebert), review of neurological manifestations of hypothyroidism, 2019 (via PubMed): Central nervous system manifestations of hypothyroidism include cerebellar ataxia, cognitive slowing, and motor coordination deficits that can affect speech
5. CDC, Newborn Screening: Congenital hypothyroidism affects approximately 1 in 2,000 to 1 in 4,000 newborns in the United States
6. Rovet et al., Journal of Pediatrics, language and speech outcomes in children with congenital hypothyroidism, 2012 (via PubMed): Children with congenital hypothyroidism, despite early levothyroxine treatment, scored significantly lower on expressive language and phonological processing tests than healthy controls
7. American Academy of Pediatrics, patient care guidance on newborn and infant care: AAP recommends repeat thyroid screening for children with Down syndrome, Turner syndrome, or family history of thyroid disease
8. Murray et al., American Journal of Speech-Language Pathology, Rapid Syllable Transition Treatment for CAS, 2015 (via PubMed): DTTC and ReST are among the most evidence-supported treatments for childhood apraxia of speech, showing improvement with intensive practice
9. Casey et al., New England Journal of Medicine, Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy, 2019: Children born to mothers with treated subclinical hypothyroidism did not have significantly higher IQ scores at age 5 than those born to untreated mothers, complicating earlier assumptions about maternal thyroid treatment benefit
10. AAP Bright Futures, developmental surveillance and screening guidelines: AAP Bright Futures recommends formal developmental screening at 9, 18, and 30 months at well-child visits
11. U.S. Department of Education, IDEA (Individuals with Disabilities Education Act): Part C of IDEA entitles children under age 3 with developmental delays to free evaluation and early intervention services; Part B covers ages 3 through 21
12. ASHA, Acquired Apraxia of Speech Practice Portal: Acquired apraxia of speech involves disrupted motor planning for speech and can result from neurological damage including that caused by systemic medical conditions